Researchers Find Blood Marker that Defines Which Patients Will Respond to Colorectal Cancer Drug (VIDEO)

University Health Network

Caption

Researchers at the Princess Margaret Cancer Centre have identified a marker that shows up in a blood test that determines which patients with colorectal cancer that has spread would benefit from receiving the drug cetuximab.

Credit

UHN

Usage Restrictions

Credit UHN

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.